Gene-editing firm gets Monsanto investment
The seed and agrochemicals corporation acquired an equity stake in TargetGene and will use protein-expression technology from Nomad Bioscience in new agri products as it looks to access new technologies.
The seed and agrochemicals corporation acquired an equity stake in TargetGene and will use protein-expression technology from Nomad Bioscience in new agri products as it looks to access new technologies.
Copyright PEI Media
Not for publication, email or dissemination